Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mariarosaria Campise"'
Autor:
Cristina Novembrino, Umberto Cornelli, Mariarosaria Campise, Antonio Tarantino, Fabrizia Bamonti, S. Ippolito, Bruno Mario Cesana, S. Lonati, Claudio Ponticelli
Publikováno v:
Transplantation. 76:1474-1478
Background Little information is available about the role of oxidative stress in renal transplant patients. To evaluate the prevalence and severity of oxidative stress in renal transplantation, the authors conducted a cross-sectional study. Methods I
Autor:
Antonio Tarantino, Giuseppe Montagnino, Fulvia Ceccarini, Erminio Bonizzoni, Claudio Ponticelli, Patrizia Passerini, Adriana Aroldi, Mariarosaria Campise
Publikováno v:
Transplantation. 78(5)
BACKGROUND It is still unknown whether it is better to administer cyclosporine (CsA) once or twice a day to renal-transplant patients. METHODS Fifty-four patients were randomized to receive CsA once a day (OD group, 28 patients) or twice a day (BD gr
Publikováno v:
Transplantation proceedings. 35(4)
The occurrence of a rapidly progressive necrotizing glomerulonephritis after kidney transplantation is exceptional and usually leads to graft failure. We describe a case of necrotizing glomerulonephritis that developed 5 months after renal transplant
Autor:
Antonio Tarantino, Roberto Confalonieri, Mariarosaria Campise, Alberto Montoli, Luigi Minetti, Claudio Ponticelli, Giuseppe D'Amico, Isabella Damilano, Antonella Bucci, Colasanti G, Giovanni Banfi
Publikováno v:
Kidney International. (2):618-623
Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. We report the clinical outcome of 105 essential mixed cryoglobulinemia (EMC) patients with renal involvement collected throughout 25 years in three renal Units o
Autor:
Mariarosaria Campise, Giorgio Graziani, Claudio Ponticelli, Monica Crepaldi, J. Lobo, S. Casati
Publikováno v:
Nephrology Dialysis Transplantation. 4:718-720
In 11 chronic haemodialysis patients we investigated whether the increase in haematocrit during recombinant human erythropoietin (rHuEPO) treatment might alter the long-term efficiency of haemodialysis. After correction of anaemia with rHuEPO (mean H